Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (26)
Bone Marrow Transplantation (18)
British Journal of Cancer (6)
Oncogenesis (1)
Blood Cancer Journal (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (41)
Correspondence (7)
Special Features (6)
Amendments and Corrections (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Chemical biology
Diseases
Drug discovery
Genetics
Health care
Immunology
Medical research
Pathogenesis
Physiology
Plant sciences
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 56 results

Advanced filters: Author: D Caillot Clear advanced filters

Glucose metabolism controls monocyte homeostasis and migration but has no impact on atherosclerosis development in mice

Monocytes participate in plaque formation, and adapt to metabolic changes to alter their functions. Here the authors show, using genetic mouse models and functional analyses, that Glut1-mediated glucose metabolism is important for regulating monocyte homeostasis and migration, but curiously has no impact on atherosclerotic plaque formation.

Alexandre Gallerand
Bastien Dolfi
Stoyan Ivanov
ResearchOpen Access19 Oct 2024
Nature Communications

Volume: 15, P: 1-16
Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells

M Assem
S Bonvalot
B Chauffert
Research01 Oct 1994
British Journal of Cancer

Volume: 70, P: 631-635
Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis

Patterson, Firulyova, et al. report that TREM2 is a key regulator of foamy macrophage differentiation. Myeloid-specific deletion of Trem2 caused increased macrophage susceptibility to cholesterol-mediated toxicity and cell death and significantly attenuated atherosclerotic plaque progression in mice.

Michael T. Patterson
Maria M. Firulyova
Jesse W. Williams
ResearchOpen Access30 Oct 2023
Nature Cardiovascular Research

Volume: 2, P: 1015-1031
Increase in the incidence of non-Hodgkin's lymphomas: evidence for a recent sharp increase in France independent of AIDS

PM Carli
MC Boutron
T Petrella
Research01 Oct 1994
British Journal of Cancer

Volume: 70, P: 713-715
Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure

JM Rebibou
D Caillot
H Guy
Research01 Jul 1997
Bone Marrow Transplantation

Volume: 20, P: 63-65
View of healthcare professionals on ultra-rapid genome sequencing and its future implementation in clinical practice for critically ill children

Claire Caillot
Etienne Javouhey
Nicolas Chatron
ResearchOpen Access23 May 2025
European Journal of Human Genetics

Volume: 33, P: 937-944
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

Nico Gagelmann
Diderik-Jan Eikema
Nicolaus Kröger
Research24 Jul 2020
Bone Marrow Transplantation

Volume: 56, P: 210-217
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma

Zoé Van de Wyngaert
Virginie Nerich
Xavier Leleu
Research23 May 2020
Bone Marrow Transplantation

Volume: 55, P: 2254-2260
Chemical inhibitors of monogalactosyldiacylglycerol synthases in Arabidopsis thaliana

Mono- and digalactosyldiacylglycerols (MGDGs and DGDGs) are glycolipids that are central to plant metabolism and photosynthetic membrane biogenesis. Galvestine-1, a small molecule inhibitor of MGDG synthases that was identified in a high-throughput chemical screen in Arabidopsis thaliana, reveals a new role for these galactolipids in pollen-tube development.

Cyrille Y Botté
Michael Deligny
Eric Maréchal
Research25 Sept 2011
Nature Chemical Biology

Volume: 7, P: 834-842
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

E Wattel
E Solary
P Fenaux
Research16 Apr 1999
Leukemia

Volume: 13, P: 524-529
Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)

C Preudhomme
N Henic
P Fenaux
Research01 Feb 1997
Leukemia

Volume: 11, P: 294-298
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol

A Riccardi
O Mora
E Ascari
Research01 Feb 1998
British Journal of Cancer

Volume: 77, P: 485-491
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years

Philipp Berning
Mathilde Fekom
Norbert Schmitz
ResearchOpen Access05 Jul 2024
Blood Cancer Journal

Volume: 14, P: 1-13
Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population

M Maynadié
C Verret
PM Carli
Research01 Jul 1996
British Journal of Cancer

Volume: 74, P: 288-290
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder

V Levy
V Ugo
F Ajchenbaum-Cymbalista
Research09 Sept 1999
Leukemia

Volume: 13, P: 1343-1351
Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

X Thomas
P Fenaux
E Archimbaud
Research09 Aug 1999
Leukemia

Volume: 13, P: 1214-1220
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study

G Marit
F Thiessard
J Reiffers
Research02 Sept 1998
Leukemia

Volume: 12, P: 1447-1456
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)

E Deconinck
J-Y Cahn
P Hervé
Research01 Nov 1997
Bone Marrow Transplantation

Volume: 20, P: 731-735
Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice

B Chauffert
H Pelletier
F Martin
Research01 Sept 1990
British Journal of Cancer

Volume: 62, P: 395-397
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study

A Riccardi
O Mora
E Ascari
ResearchOpen Access07 Mar 2000
British Journal of Cancer

Volume: 82, P: 1254-1260
Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experience

V Lapierre
J-F Rossi
C Chabannon
Research18 Oct 2010
Bone Marrow Transplantation

Volume: 46, P: 936-942
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial

S de Botton
S Chevret
P Fenaux
Research18 Feb 2003
Leukemia

Volume: 17, P: 339-342
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)

M Michallet
X Thomas
E Archimbaud
Research13 Dec 2000
Bone Marrow Transplantation

Volume: 26, P: 1157-1163
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial

Francois Guilhot
Françoise Rigal-Huguet
Franck-Emmanuel Nicolini
Research22 Jan 2021
Leukemia

Volume: 35, P: 2332-2345
Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa

L Ysebaert
E Deconinck
JY Cahn
Research12 Jun 2002
Bone Marrow Transplantation

Volume: 29, P: 873-874
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud
Pascale Cornillet-Lefebvre
A. Fayault
Research18 Sept 2020
Leukemia

Volume: 35, P: 1291-1300
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells

M. Caillot
J. Bourgeais
B. Sola
ResearchOpen Access24 Jul 2020
Oncogenesis

Volume: 9, P: 1-13
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Sebastian Giebel
Myriam Labopin
Mohamad Mohty
Research07 Jan 2023
Bone Marrow Transplantation

Volume: 58, P: 393-400
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

B Hebraud
X Leleu
H Avet-Loiseau
Research29 Jul 2013
Leukemia

Volume: 28, P: 675-679
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

P Moreau
M Attal
H Avet-Loiseau
Research12 Jul 2007
Leukemia

Volume: 21, P: 2020-2024
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network

H Ludwig
M Delforge
P Sonneveld
ReviewsOpen Access18 Dec 2017
Leukemia

P: 1-46
Legionellosis after hematopoietic stem cell transplantation

Malgorzata Mikulska
Gloria Tridello
Jan Styczynski
Research22 May 2021
Bone Marrow Transplantation

Volume: 56, P: 2555-2566
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia

X Thomas
D Fiere
✠E Archimbaud
Correspondence02 Sept 1998
Leukemia

Volume: 12, P: 1503-1505
Erratum: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

B Hebraud
X Leleu
H Avet-Loiseau
Amendments and Corrections05 Mar 2014
Leukemia

Volume: 28, P: 726
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

E Solary
L Mannone
P Genne
Research20 Dec 2000
Leukemia

Volume: 14, P: 2085-2094
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

Maroulio Pertesi
Maxime Vallée
Charles Dumontet
ResearchOpen Access09 Apr 2019
Leukemia

Volume: 33, P: 2324-2330
Survey on haematopoietic stem cell transplantation for children in Europe

M Miano
R Cancedda
G Dini
Research06 Apr 2005
Bone Marrow Transplantation

Volume: 35, P: S3-S8
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

X Leleu
G Fouquet
P Moreau
Correspondence05 Apr 2013
Leukemia

Volume: 27, P: 2242-2244
Minimally differentiated acute myeloid leukemia (AML-M0) with lymphoid presentation at relapse: a case report

L Ysebaert
PM Carli
M Maynadié
Correspondence04 Oct 2001
Leukemia

Volume: 15, P: 1673-1674
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

A Toma
O Kosmider
F Dreyfus
Research26 Oct 2015
Leukemia

Volume: 30, P: 897-905
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

N Vey
X Thomas
J Gabert
Research12 Oct 2006
Leukemia

Volume: 20, P: 2155-2161
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial

P Moreau
C Hulin
J L Harousseau
Correspondence29 Apr 2010
Leukemia

Volume: 24, P: 1233-1235
Exposure to hydroxyurea during pregnancy: a case series

C Thauvin-Robinet
C Maingueneau
A Nivelon-Chevallier
Correspondence26 Jul 2001
Leukemia

Volume: 15, P: 1309-1311
Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

F Millot
H Esperou
F Guilhot
Research03 Nov 2003
Bone Marrow Transplantation

Volume: 32, P: 993-999
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience

H Avet-Loiseau
M Roussel
B Royer
Correspondence29 Jul 2011
Leukemia

Volume: 26, P: 158-159
Hematopoietic stem cell transplantation for hematological malignancies in Europe

A Gratwohl
H Baldomero
A Urbano-Ispizua
Research15 May 2003
Leukemia

Volume: 17, P: 941-959
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

C Graux
M Stevens-Kroef
H A Poirel
Research16 Oct 2008
Leukemia

Volume: 23, P: 125-133
FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

S Camilleri-Broët
N Mounier
C Sautès-Fridman
Correspondence07 Oct 2004
Leukemia

Volume: 18, P: 2038-2040
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation

M Miano
M Labopin
G Dini
Research10 Jan 2007
Bone Marrow Transplantation

Volume: 39, P: 89-99
NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique

S P Romana
I Radford-Weiss
R Berger
Research09 Feb 2006
Leukemia

Volume: 20, P: 696-706

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited